News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ceragenix Pharmaceuticals, Inc. (CGXP.OB) Release: Research On Ceragenins To Be Highlighted At Leading International Conference On Infectious Disease


9/20/2006 11:33:37 AM

DENVER--(BUSINESS WIRE)--Sept. 20, 2006--Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on infectious disease and dermatology, today announced that Dr. Paul Savage, Professor of Chemistry in the Department of Chemistry at Brigham Young University, has been selected to be the opening speaker during the "All New Antimicrobial Agents" session of the 46th annual meeting of the American Society for Microbiology's (ASM's) Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), which is being held at the Moscone Center in San Francisco from September 27 - 29, 2006.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES